Protara Therapeutics(TARA) - 2024 Q1 - Quarterly Results

Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update NEW YORK, May 2, 2024 – Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the first quarter ended March 31, 2024 and provided a business update. "We have made significant progress thus far in 2024, and with cash resources expected to fund operations into 2026, we are well pos ...